期刊文献+

炎症性肠病肠上皮细胞修复机制的研究进展 被引量:9

Research progress on repair mechanism of intestinal epithelial cells in inflammatory bowel disease
下载PDF
导出
摘要 肠上皮细胞及其之间的紧密连接是肠黏膜屏障的重要组成部分。炎症性肠病中可出现肠上皮屏障的损伤,会导致肠黏膜的反复受损和修复。上皮损伤的修复取决于附近上皮细胞的迁移、增殖和分化。多种生长因子、细胞因子、三叶因子参与了调节肠道上皮损伤的修复,近年来还发现固有免疫中的Toll样受体和NOD样受体对维持肠内稳态和肠黏膜修复也起着重要作用。 Intestinal epithelial cells and tight intercellular junction are important components of intestinal mucosal barrier. The epithelial barrier damage may occur in inflammatory bowel disease, which leads to recurrent injury and repair of the intestinal mucosa. The process of epithelial injury repair relies upon the migration, proliferation and differentiation of adjacent epithelial cells. Multiple growth factors, cytokines and trefoil factors participate in regulating the process of intestinal epithelial injury repair. In recent years, toll-like receptors and NOD-like receptors in innate immunity have also been found to play a pivotal role in maintaining intestinal homeostasis and intestinal mucosal repair.
作者 宋铱航 钟英强 Song Yihang;Zhong Yingqiang(Department of Gastroenterology, Sun Yat- sen Memorial Hospital, Sun Yat- sen University, Guangzhou 510120, China)
出处 《新医学》 2019年第2期80-84,共5页 Journal of New Medicine
基金 广州市科技计划项目(201803010004)
关键词 炎症性肠病 上皮细胞 细胞修复 胞间信号肽类和蛋白质类 固有免疫 Inflammatory bowel disease Epithelial cell Cell repair Intercellular signaling peptide and protein Innate immunity
  • 相关文献

参考文献5

二级参考文献31

  • 1Paterlini MG. Structure modeling of the chemokine recep- tor CCRS: implications for ligand binding and selectivity [J]. Biophys J,2002,83(6) :3012-3031.
  • 2Zhang ZF, Shah X, Wang YX, et al. Screening and se- lection of peptides specific for esophageal cancer cells from a phage display peptide library [ J ]. J Cardiothorac Surg, 2014,9:76.
  • 3Wang FY, Zhang TY, Luo JX, et al. Selection of CC che- mokine receptor 5-binding peptide from a phage display peptide library [ J ]. Biosci Biotechnol Biochem, 2006,70 (9) :2035-2041.
  • 4Schnur E, Kessler N, Zherdev Y, et al. NMR mapping of RANTES surfaces interacting with CCR5 using linked ex- tracellular domains [ J ]. FEBS J, 2013,280 (9) : 2068- 2084.
  • 5Lee B, Sharron M, Blanpain C, et al. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and core- ceptor function [ J ]. J Biol Chem, 1999,274 (14) : 9617- 9626.
  • 6Ajuebor MN, Hogaboam CM, Kunkel SL, et al. The che- mokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat [ J ]. J Immunol, 2001,166( 1 ) :552-558.
  • 7Eltayeb S, Sunnemark D, Berg AL, et al. Effector stage CC chemokine receptor-1 selective antagonism reduces multiple sclerosis-like rat disease [ J ]. J Neuroimmunol, 2003,142(1-2) :75-85.
  • 8Cumming JG, Tucker H, Oldfield J, et al. Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treat- ment of rheumatoid arthritis [ J ]. Bioorg Med Chem Lett, 2012,22(4) : 1655-1659.
  • 9Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4 + cells is mediated by the ehemokine receptor CC- CKR-5 [ J ]. Nature, 1996,381 (6584) :667-673.
  • 10Matsuzaki K, Hokari R, Kato S, et al. Differential ex- pression of CCR5 and CRTH2 on infiltrated cells in colonic mucosa of patients with ulcerative colitis [ J ]. J Gastroen- terol Hepatol, 2003,18 (9) : 1081-1088.

共引文献71

同被引文献77

引证文献9

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部